Makhzoumi Mohamad — SEC Form 4 filings
SEC reporting owner CIK 1630226. 12 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-04-10 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 2,216,707 shares, $28,074,473 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 75.
- Largest priced transaction: purchase of 937,500 shares @ $16.00 ($15,000,000) in SpyGlass Pharma, Inc., filed 2026-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | 10% owner | 1 | 1 leg · 937,500 sh · $15,000,000 | — | 12 |
| MBX Biosciences, Inc. (MBX) | 10% owner | 1 | 1 leg · 500,000 sh · $8,000,000 | — | 4 |
| Korro Bio, Inc. (KRRO) | 10% owner | 2 | 2 legs · 224,957 sh · $3,300,873 | — | 1 |
| Marker Therapeutics, Inc. (MRKR) | 10% owner | 1 | 1 leg · 554,250 sh · $1,773,600 | — | — |
| NeueHealth, Inc. (NEUE) | Director, 10% owner | 5 | — | — | 54 |
| SYNLOGIC, INC. (SYBX) | Director, 10% owner | 1 | — | — | 2 |
| Senti Biosciences, Inc. (SNTI) | 10% owner | 1 | — | — | 2 |
Form 4 filings — Makhzoumi Mohamad
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | SYNLOGIC, INC. (SYBX) jointly with New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Florence Anthony A. Jr., SANDELL SCOTT D | Code (H): 2,640,845 (derivative) · Purchase (P): 2,640,845 (derivative) | EDGAR |
| 2026-03-12 | 4 | Korro Bio, Inc. (KRRO) | Purchase (P): 207,100 @ $11.11 · Purchase (P): 242,945 (derivative) @ $11.11 | EDGAR |
| 2026-02-11 | 4 | SpyGlass Pharma, Inc. (SGP) | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2025-10-06 | 4 | NeueHealth, Inc. (NEUE) | Option exercise (M): 189,195 @ $0.01 · Tax withholding (F): 280 @ $6.75 · Option exercise (M): 434,297 @ $0.01 · Tax withholding (F): 643 @ $6.75 · Disposition to issuer (D): 1,960,591 · Disposition to issuer (D): 43,678 · +35 more | EDGAR |
| 2025-05-15 | 4 | NeueHealth, Inc. (NEUE) | Option exercise (M): 10,500 @ $0 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Senti Biosciences, Inc. (SNTI) jointly with New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, BASKETT FOREST, Florence Anthony A. Jr., SANDELL SCOTT D | Conversion (C): 3,333,000 · Conversion (C): 3,333 (derivative) | EDGAR |
| 2024-12-23 | 4 | Marker Therapeutics, Inc. (MRKR) jointly with New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, BASKETT FOREST, Chang Carmen, Behbahani Ali, Florence Anthony A. Jr., SANDELL SCOTT D, Walker Paul Edward | Purchase (P): 554,250 @ $3.20 | EDGAR |
| 2024-10-03 | 4 | NeueHealth, Inc. (NEUE) | Grant/award (A): 61,865 (derivative) · Grant/award (A): 61,865 (derivative) · Grant/award (A): 61,865 (derivative) · Grant/award (A): 185,595 (derivative) | EDGAR |
| 2024-09-17 | 4 | MBX Biosciences, Inc. (MBX) | Conversion (C): 1,023,103 · Conversion (C): 2,091,383 · Purchase (P): 500,000 @ $16 · Conversion (C): 12,299,854 (derivative) · Conversion (C): 25,142,840 (derivative) | EDGAR |
| 2024-05-14 | 4 | NeueHealth, Inc. (NEUE) | Option exercise (M): 4,755 @ $0 · Option exercise (M): 4,755 (derivative) @ $0 · Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | Korro Bio, Inc. (KRRO) | Purchase (P): 17,857 @ $56 | EDGAR |
| 2024-04-10 | 4 | NeueHealth, Inc. (NEUE) | Grant/award (A): 123,729 (derivative) · Grant/award (A): 123,729 (derivative) · Grant/award (A): 123,729 (derivative) · Grant/award (A): 371,187 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1630226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →